{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:15:01Z","timestamp":1776770101498,"version":"3.51.2"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"DOI":"10.7759\/cureus.68386","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T15:04:41Z","timestamp":1725203081000},"source":"Crossref","is-referenced-by-count":1,"title":["Transition of Online Adaptive Stereotactic Radiotherapy for Pancreatic Cancer From Magnetic Resonance-Guided Linear Accelerator (MR-Linac) to State-of-the-Art Cone-Beam Computed Tomography (CBCT)"],"prefix":"10.7759","author":[{"given":"Laura A","family":"Rechner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Felter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Bekke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Biancardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne F","family":"R\u00f8njom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sj\u00f6str\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna M","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"Sibolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i44.9694","article-title":"Epidemiology of pancreatic cancer","volume":"22","author":"Ilic M","year":"2016","unstructured":"Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016, 22:9694-705. 10.3748\/wjg.v22.i44.9694","journal-title":"World J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan A","year":"2018","unstructured":"McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018, 24:4846-61. 10.3748\/wjg.v24.i43.4846","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos JP","year":"2004","unstructured":"Neoptolemos JP, Stocken DD, Friess H, et al.. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004, 350:1200-10. 10.1056\/NEJMoa032295","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.3446","article-title":"Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012\/FFCD-9203\/GERCOR phase II study","volume":"28","author":"Van Laethem JL","year":"2010","unstructured":"Van Laethem JL, Hammel P, Mornex F, et al.. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012\/FFCD-9203\/GERCOR phase II study. J Clin Oncol. 2010, 28:4450-6. 10.1200\/JCO.2010.30.3446","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.10.030","article-title":"Stereotactic body radiotherapy (SBRT) for locally advanced pancreatic cancer: a systematic review and pooled analysis of 19 trials","volume":"97","author":"Petrelli F","year":"2017","unstructured":"Petrelli F, Comito T, Ghidini A, Torri V, Scorsetti M, Barni S. Stereotactic body radiotherapy (SBRT) for locally advanced pancreatic cancer: a systematic review and pooled analysis of 19 trials. Int J Radiat Oncol Biol Phys. 2017, 97:313-22. 10.1016\/j.ijrobp.2016.10.030","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.4324","article-title":"Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial","volume":"315","author":"Hammel P","year":"2016","unstructured":"Hammel P, Huguet F, van Laethem JL, et al.. Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial. JAMA. 2016, 315:1844-53. 10.1001\/jama.2016.4324","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2004.12.022","article-title":"Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma","volume":"76","author":"Hoyer M","year":"2005","unstructured":"Hoyer M, Roed H, Sengelov L, et al.. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol. 2005, 76:48-53. 10.1016\/j.radonc.2004.12.022","journal-title":"Radiother Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.12.003","article-title":"Focal radiation therapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation","volume":"94","author":"Krishnan S","year":"2016","unstructured":"Krishnan S, Chadha AS, Suh Y, et al.. Focal radiation therapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation. Int J Radiat Oncol Biol Phys. 2016, 94:755-65. 10.1016\/j.ijrobp.2015.12.003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.888462","article-title":"Induction chemotherapy and ablative stereotactic magnetic resonance image-guided adaptive radiation therapy for inoperable pancreas cancer","volume":"12","author":"Chuong MD","year":"2022","unstructured":"Chuong MD, Herrera R, Kaiser A, et al.. Induction chemotherapy and ablative stereotactic magnetic resonance image-guided adaptive radiation therapy for inoperable pancreas cancer. Front Oncol. 2022, 12:888462. 10.3389\/fonc.2022.888462","journal-title":"Front Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2020.09.005","article-title":"Ablative 5-fraction stereotactic magnetic resonance-guided radiation therapy with on-table adaptive replanning and elective nodal irradiation for inoperable Pancreas cancer","volume":"11","author":"Chuong MD","year":"2021","unstructured":"Chuong MD, Bryant J, Mittauer KE, et al.. Ablative 5-fraction stereotactic magnetic resonance-guided radiation therapy with on-table adaptive replanning and elective nodal irradiation for inoperable Pancreas cancer. Pract Radiat Oncol. 2021, 11:134-47. 10.1016\/j.prro.2020.09.005","journal-title":"Pract Radiat Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2020.06.010","article-title":"Ablative five-fraction stereotactic body radiation therapy for inoperable pancreatic cancer using online MR-guided adaptation","volume":"6","author":"Hassanzadeh C","year":"2021","unstructured":"Hassanzadeh C, Rudra S, Bommireddy A, et al.. Ablative five-fraction stereotactic body radiation therapy for inoperable pancreatic cancer using online MR-guided adaptation. Adv Radiat Oncol. 2021, 6:100506. 10.1016\/j.adro.2020.06.010","journal-title":"Adv Radiat Oncol"},{"key":"ref12","unstructured":"ViewRay\u00ae files voluntary chapter 11 petitions. (2024). Accessed. July 23, 2024: https:\/\/www.sec.gov\/Archives\/edgar\/data\/1597313\/000162828023024952\/ex-991xpressrelease.htm."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phro.2020.12.004","article-title":"Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region","volume":"17","author":"Sibolt P","year":"2021","unstructured":"Sibolt P, Andersson LM, Calmels L, Sj\u00f6str\u00f6m D, Bjelkengren U, Geertsen P, Behrens CF. Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region. Phys Imaging Radiat Oncol. 2021, 17:1-7. 10.1016\/j.phro.2020.12.004","journal-title":"Phys Imaging Radiat Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2023.10.014","article-title":"Novel technology allowing cone beam computed tomography in 6 seconds: a patient study of comparative image quality","volume":"14","author":"Robar JL","year":"2024","unstructured":"Robar JL, Cherpak A, MacDonald RL, et al.. Novel technology allowing cone beam computed tomography in 6 seconds: a patient study of comparative image quality. Pract Radiat Oncol. 2024, 14:277-86. 10.1016\/j.prro.2023.10.014","journal-title":"Pract Radiat Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-022-02125-z","article-title":"The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR)","volume":"17","author":"Kim M","year":"2022","unstructured":"Kim M, Schiff JP, Price A, et al.. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR). Radiat Oncol. 2022, 17:157. 10.1186\/s13014-022-02125-z","journal-title":"Radiat Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2023.100692","article-title":"A feasibility trial of skin surface motion-gated stereotactic body radiotherapy for treatment of upper abdominal or lower thoracic targets using a novel O-ring gantry","volume":"44","author":"Kiser K","year":"2024","unstructured":"Kiser K, Schiff J, Laugeman E, et al.. A feasibility trial of skin surface motion-gated stereotactic body radiotherapy for treatment of upper abdominal or lower thoracic targets using a novel O-ring gantry. Clin Transl Radiat Oncol. 2024, 44:100692. 10.1016\/j.ctro.2023.100692","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2022.08.026","article-title":"Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer","volume":"175","author":"Schiff JP","year":"2022","unstructured":"Schiff JP, Price AT, Stowe HB, et al.. Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer. Radiother Oncol. 2022, 175:144-51. 10.1016\/j.radonc.2022.08.026","journal-title":"Radiother Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/281546-transition-of-online-adaptive-stereotactic-radiotherapy-for-pancreatic-cancer-from-magnetic-resonance-guided-linear-accelerator-mr-linac-to-state-of-the-art-cone-beam-computed-tomography-cbct","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T15:04:45Z","timestamp":1725203085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/281546-transition-of-online-adaptive-stereotactic-radiotherapy-for-pancreatic-cancer-from-magnetic-resonance-guided-linear-accelerator-mr-linac-to-state-of-the-art-cone-beam-computed-tomography-cbct"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.68386","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}